Anti-emetics in oncology
Mahjoubi, M.; Lopez, C.; Pallard, M.C.; Droz, J.P.
Revue de l'Infirmiere 40(19): 35-37
1990
ISSN/ISBN: 1293-8505 PMID: 2091208 Document Number: 355563
Document emailed within 1 workday
Related Documents
Tattersall, R.N. 1971: Emetics Practitioner 206(231): 111-113Jägervall, M.; Lindberg, U. 1989: Emetics to induce vomiting in children Lakartidningen 86(6): 432-433
Wils, J. 2002: Anti-cancer treatment - 12th International Congress. Third Interactive Gastrointestinal Oncology Meeting. 4-7 February 2002, Paris, France IDrugs: the investigational drugs journal 5(3): 224-227
Ruggeri, B.A.; Miknyoczki, S.J.; Singh, J.; Hudkins, R.L. 1999: Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models Current Medicinal Chemistry 6(9): 845-857
Gori, S.; Di Maio, M.; Pinto, C.; Alabiso, O.; Baldini, E.; Beretta, G.Domenico.; Caffo, O.; Caroti, C.; Crinò, L.; De Laurentiis, M.; Dinota, A.; Di Vito, F.; Gebbia, V.; Giustini, L.; Graiff, C.; Guida, M.; Lelli, G.; Lombardo, M.; Muggiano, A.; Puglisi, F.; Romito, S.; Salvagno, L.; Tagliaferri, P.; Terzoli, E.; Venturini, M. 2010: Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM) Tumori 96(6): 1010-1015
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Kubal, T.; Peabody, J.W.; Friedman, E.; Levine, R.; Pursell, S.; Letson, D.G. 2015: Using Vignettes to Measure and Encourage Adherence to Clinical Pathways in a Quality-Based Oncology Network: An Early Report on the Moffitt Oncology Network Initiative Managed Care 24(10): 56-64
Lamkin, L.; Rosiak, J.; Buerhaus, P.; Mallory, G.; Williams, M. 2001: Oncology Nursing Society Workforce Survey. Part I: Perceptions of the nursing workforce environment and adequacy of nurse staffing in outpatient and inpatient oncology settings Oncology nursing forum 28(10): 1545-1552
Durand, J.-P.; Goldwasser, F.ço. 2003: New challenges in medical oncology. from medical oncology to oncological medicine Annales de Medecine Interne 154(3): 131-132
Kazimierska, E.; Górski, J. 1989: Anti-HBS, anti-CMV, and anti-HIV antibodies and HBS antigen in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma Acta Haematologica Polonica 20(2): 189-194
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Lebacq, A.M.; Goffinet, P.; De Bruyere, M.; Rodhain, J.; Sokal, G. 1982: Membrane marker studies with anti-T, anti-Ia (DR) and anti-myeloblast antisera in acute leukaemias European Journal of Cancer and Clinical Oncology 18(2): 147-153
Kumagai, T.; Kameko, M.; Kanai, M.; Maruyama, K. 1985: A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 293-297
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849
Devaux, C.; Pierres, M. 1982: Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies Journal of Immunology 128(2): 751-757
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Tanaka, M. 2005: RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 449-452
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358